Efficacy of Different Combinations of Direct-Acting Antivirals Against Different Hepatitis C Virus-Infected Population Groups: An Experience in Tertiary Care Hospitals in West Bengal, India
Viruses · 2025
DOI: 10.3390/v17020269 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Sagnik Bakshi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Indian Council of Medical Research, National Institute for Research in Bacterial Infections P-33, Scheme XM, CIT Road, Beliaghata, Kolkata 700010, We…. Hauptthemen laut MEDLINE: Antiviral Agents, Hepacivirus, Hepatitis C, Chronic, Hepatitis C. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indian Council of Medical Research, The Indian Council of Medical Research-National Institute for Research in Bacterial Infections (ICMR-NIRBI, formerly ICMR-NICED).
Abstract (Originalsprache)
Hepatitis C virus (HCV) is a global public health problem, but advancements in HCV treatment have improved the cure rate. This study evaluated the effectiveness of direct-acting antivirals (DAAs) in HCV-infected patients from May 2021 to April 2023 in collaboration with tertiary care hospitals in West Bengal. The HCV viral load was monitored via qRT-PCR. Sanger sequencing was performed to determine the HCV genotypes. The clinicians prescribed the patient treatment regime. The maximum number of patients in the study population (N = 398) were compensated cirrhosis patients (46.28%). The overall SVR rate of the study population was 94.47%. The decompensated cirrhosis patients experienced the lowest SVR rate (88.89%). The maximum number of patients were prescribed sofosbuvir/daclatasvir (63.77%), and the lowest SVR rate (93.23%) was observed with this treatment regime. In the study population, GT-3 was the predominant (67.43%) circulating genotype, followed by GT-1 and -4. Among 398 patients, 22 (5.53%) were non-responsive to DAA treatment. Out of these 22 non-responder patients, 77.27% (n = 17) were GT-3-infected (3a:10; 3b:07), followed by GT-1 (1c: 04; 1b: 01). Thus, increasing numbers of DAA non-responsive cases among HCV GT-3-infected and decompensated cirrhosis patients may pose serious threats in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Indian Council of Medical Research, National Institute for Research in Bacterial Infections P-33, Scheme XM, CIT Road, Beliaghata, Kolkata 700010, West Bengal, India.
- College of Medicine & Sagore Dutta Hospital, 578 B.T Road, Kolkata 700058, West Bengal, India.
- IPGME&R and SSKM Hospital, SSKM Hospital Rd, Bhowanipore, Kolkata 700020, West Bengal, India.
ORCID-Profile: Sagnik Bakshi, Partha Chattopadhyay, Raina Das, Supradip Dutta, Shreyasi Nath, Upasana Baskey
Förderung
- Indian Council of Medical Research
- The Indian Council of Medical Research-National Institute for Research in Bacterial Infections (ICMR-NIRBI, formerly ICMR-NICED)
Zitieren
APA
Bakshi, S., Chattopadhyay, P., Ahammed, M., Das, R., Majumdar, M., Dutta, S., Nath, S., Ghosh, A., Bhattacharjee, U., Baskey, U., & Sadhukhan, P. C. (2025). Efficacy of Different Combinations of Direct-Acting Antivirals Against Different Hepatitis C Virus-Infected Population Groups: An Experience in Tertiary Care Hospitals in West Bengal, India. Viruses. https://doi.org/10.3390/v17020269
Vancouver
Bakshi S, Chattopadhyay P, Ahammed M, Das R, Majumdar M, Dutta S, et al. Efficacy of Different Combinations of Direct-Acting Antivirals Against Different Hepatitis C Virus-Infected Population Groups: An Experience in Tertiary Care Hospitals in West Bengal, India. Viruses. 2025. doi:10.3390/v17020269
BibTeX
@article{Bakshi2025,
author = {Bakshi, Sagnik and Chattopadhyay, Partha and Ahammed, Mahiuddin and Das, Raina and Majumdar, Moumita and Dutta, Supradip and Nath, Shreyasi and Ghosh, Anwesha and Bhattacharjee, Uttaran and Baskey, Upasana and Sadhukhan, Provash Chandra},
title = {Efficacy of Different Combinations of Direct-Acting Antivirals Against Different Hepatitis C Virus-Infected Population Groups: An Experience in Tertiary Care Hospitals in West Bengal, India},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17020269}
}
EUVIMED